business / news / / Outlook Business
Mumbai-based drugmaker has completed more than three months of detailed due diligence.
Sun Pharma is preparing a $12 billion all-cash bid to acquire Organon & Co.
KEY POINTS
- This would be the largest overseas acquisition ever attempted by an Indian pharmaceutical company.
- Sun Pharma has secured backing from JPMorgan, MUFG, Standard Chartered, and Citi for the bid.
- Organon carries $9.5 billion in debt inherited from its 2021 spinoff from MSD.
- Two other international consortiums are also competing to acquire Organon, with Morgan Stanley advising.
COMPANIES
Summarized by Newsio from Outlook Business. How we summarize →